Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
AAP updates interim COVID-19 guidance
The AAP updated its interim guidance on when and how to test children for SARS-CoV-2 infection and added a new type of mask — the elastomeric mask — to its guidance on personal protective equipment.
Mortality rate among DRC patients with severe or critical COVID-19 close to 50%
The mortality rate among patients in the Democratic Republic of the Congo with severe or critical cases of COVID-19 is nearly 50%, according to a study in The American Journal of Tropical Medicine and Hygiene.
Log in or Sign up for Free to view tailored content for your specialty!
Latent TB infection uncommon after secukinumab treatment
Latent tuberculosis infection was an uncommon adverse event after treatment with secukinumab for chronic systemic inflammatory conditions, according to a study published in JAMA Dermatology.
NIH trial will test existing drugs against COVID-19
The National Institute of Allergy and Infectious Diseases will repurpose approved or late-stage investigational therapies and test them against COVID-19 to determine if they warrant larger trials, the NIH said.
Johnson & Johnson halts COVID-19 vaccine trials due to ‘unexplained illness’
Johnson & Johnson said it has temporarily paused dosing for all of its COVID-19 vaccine trials — including a phase 3 trial that began last month — because of an “unexplained illness” in a study participant.
Antibody response in COVID-19 similar in adults with and without diabetes
Antibodies in adults with diabetes hospitalized with COVID-19 in Italy had a similar positive response to the SARS-CoV-2 spike protein as those without diabetes, according to findings published in Diabetologia.
COVID-19 gains lost after social distancing measures relaxed
Relaxing social distancing measures in the United States led to “an immediate and significant reversal” in gains made against COVID-19, researchers reported in Clinical Infectious Diseases.
Final trial results continue to show benefit from remdesivir for COVID-19
Final results from a randomized clinical trial continued to show that remdesivir shortens recovery time in hospitalized patients with COVID-19, although researchers said antiviral treatment alone is probably not sufficient for all patients.
PPE portraits help health care workers cope amid COVID-19 pandemic
Personal protective equipment can cause feelings of isolation and fear. However, PPE portraits — postcard-sized self-portraits of doctors affixed to their protective clothing — can help physicians connect with patients, researchers wrote.
Study offers reassurance of flu vaccination during COVID-19 pandemic
Influenza vaccination did not increase the incidence of COVID-19 or worsen outcomes related to the disease, researchers reported.
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read